Micron Technology, Inc. – Common
Q3 revenue $41.46 billion +345.8% Y/Y increase, which is simply ridiculous to think about! The margin story is also impressive as non-GAAP gross margin stood at 84.9%.
Segment-wise – Core data centre 7x to $11.5B, cloud memory hit $13.8B and even automotive and embedded more than quadrupled to $4.6B.
Cash generation has also been phenomenal as operating cash flow stood at $25.4B and adj. FCF at $18.3B
Micron’s gross margin, the profit left after accounting for the cost of goods sold, jumped to 84.9% in the third quarter from 74.9% in the prior period and 39% a year earlier. Margins topped analyst estimates.
Net income during the quarter was $28.24 billion, or $24.46 per share, versus $1.89 billion, or $1.68 per share in the year-ago period.
While all four of Micron’s business units saw revenue multiply, the most explosive growth was in the core data center business, where sales climbed more than sevenfold to $11.5 billion from $1.53 billion in the same period a year ago. In addition to memory, Micron also recorded over $5 billion in data center solid state drive revenue, the company said in a presentation.
Cloud memory was up over 300% to $13.77 billion.
The company’s mobile and client business unit saw a 250% growth in revenue to $11.52 billion, and even memory for automotive and embedded applications more than quadrupled to $4.63 billion in sales.
Micron Technology, Inc. – Common
Micron rose almost 7% ahead of its quarterly report due Wednesday after the bell,
NAS: SMCI said it plans to raise $7 billion in equity-related sales to cover the costs of hardware component purchases. The company also said it’s received $39 billion in artificial intelligence server orders in recent weeks.
Wednesday, June 10: Oracl.
Thursday, June 11: Adobe.
Marvell Technology, Inc. – Common: Noted – Jensen Huang’s high-profile backing of the chipmaker at Computex.
Expected Revenue & Growth: Driven by accelerating AI data center and custom silicon demand, Marvell raised its growth guidance significantly during its last earnings call:
Year-over-Year (YoY) Growth: Represents ~35% YoY growth (beating previous consensus of $2.6 billion).
Sequential Growth: Represents ~12% sequential growth from Q1 FY2027.
YoY Growth: Approximately 40% growth year-over-year.
YoY Growth: Approximately 45% growth compared to
ASX:MDT releasing Q4 and full-year fiscal 2026 results, delivering its highest annual organic revenue growth in 10 years and boosting its cash dividend. Positive sentiment was also bolstered by key FDA regulatory submissions for its Hugo robotic-assisted surgery system.
Level 17 Chifley Tower
2 Chifley Square
Sydney, NSW 2000
1300 614 002
Investor Signals Pty Ltd
ABN 44 143 555 453
